20688795

Source:http://linkedlifedata.com/resource/pubmed/id/20688795

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010181, umls-concept:C0011854, umls-concept:C0021658, umls-concept:C0030705, umls-concept:C0038995, umls-concept:C0040808, umls-concept:C0220825, umls-concept:C0332307, umls-concept:C0443252, umls-concept:C0537270, umls-concept:C1707455
pubmed:issue	1
pubmed:dateCreated	2011-1-26
pubmed:abstractText	To evaluate the long-term clinical and economic outcomes associated with insulin detemir and neutral protamine hagedorn (NPH) insulin in combination with mealtime insulin aspart in patients with type 1 diabetes in Sweden, based on data from a two-year, multi-national, open-label, randomized, controlled trial.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883503
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Isophane, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Long-Acting, http://linkedlifedata.com/resource/pubmed/chemical/insulin detemir
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1651-1905
pubmed:author	pubmed-author:AagrenMarkM, pubmed-author:EricssonAsaA, pubmed-author:GschwendManuela HMH, pubmed-author:HaglundMattiasM, pubmed-author:ValentineWilliam JWJ
pubmed:issnType	Electronic
pubmed:volume	39
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	79-87
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:20688795-Adult, pubmed-meshheading:20688795-Cohort Studies, pubmed-meshheading:20688795-Cost of Illness, pubmed-meshheading:20688795-Cost-Benefit Analysis, pubmed-meshheading:20688795-Diabetes Complications, pubmed-meshheading:20688795-Diabetes Mellitus, Type 1, pubmed-meshheading:20688795-Drug Costs, pubmed-meshheading:20688795-Female, pubmed-meshheading:20688795-Health Care Costs, pubmed-meshheading:20688795-Humans, pubmed-meshheading:20688795-Hypoglycemic Agents, pubmed-meshheading:20688795-Insulin, pubmed-meshheading:20688795-Insulin, Isophane, pubmed-meshheading:20688795-Insulin, Long-Acting, pubmed-meshheading:20688795-Male, pubmed-meshheading:20688795-Outcome Assessment (Health Care), pubmed-meshheading:20688795-Quality-Adjusted Life Years, pubmed-meshheading:20688795-Sweden, pubmed-meshheading:20688795-Time Factors
pubmed:year	2011
pubmed:articleTitle	Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden.
pubmed:affiliation	Ossian Health Economics and Communication, Basel, Switzerland.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Evaluation Studies